Tagged with Hospitals

Taiwan Bringing together clinical scale, academic depth, and a strong engineering mindset, China Medical University Hospital has positioned itself as more than a care provider. In this interview, Dr Der-Yang Cho, Superintendent and Professor of Neurosurgery, explains how the institution operates as an integrated innovation platform, advancing cell and gene therapies,…

Taiwan In 2024, Taipei Medical University reached a defining milestone. President Mai-Szu Wu oversaw a full digital transformation linking seven affiliated medical institutions and more than 3,000 beds into a unified data platform, creating a foundation for large-scale research, AI applications, and faster clinical-trial operations. This momentum has now extended nationwide…

France Raymond Le Moign leads one of Europe’s largest university hospital centres at a moment when healthcare systems are being forced to rethink how they organise care, innovation, and accountability. Drawing on experience that spans national health policy, oncology, regulation, and frontline hospital leadership, he lays out a long-term vision that…

Hong Kong Hong Kong is entering a pivotal new chapter in its healthcare and regulatory evolution. Under the leadership of Secretary for Health Professor Lo Chung-mau, the city is reshaping its position as a global bridge for medical innovation through the “1+ Mechanism,” the creation of the Centre for Medical Products Regulation,…

Hong Kong With a career spanning clinical medicine, hospital management, and healthcare policy, Dr Kenneth Tsang brings a rare depth of perspective to his dual role as Regional CEO of IHH Healthcare North Asia and CEO of Gleneagles Hospital Hong Kong. Having helped shape Hong Kong’s public healthcare system during his tenure…

Saudi Arabia Björn Bodenstein, Managing Director of Siemens Healthineers Saudi Arabia, explores the company’s commitment to supporting Saudi Vision 2030 through innovation, digital transformation, and strategic partnerships. By addressing healthcare accessibility, advancing sustainability, and nurturing local talent, Siemens Healthineers aims to play a transformative role in the Kingdom’s healthcare landscape.   Our…

Saudi Arabia Majid Al Fayyadh, CEO of King Faisal Specialist Hospital and Research Centre (KFSHRC), discusses the hospital’s transformation into a world-class medical and research institution, aligning with Saudi Arabia’s Vision 2030. He shares insights into KFSHRC’s pioneering efforts in oncology, transplantation, genetics, and cutting-edge medical technology, as well as its role…

France At the end of a turbulent and lengthy process, France’s 2025 health budget has finally been approved. This “imperfect” budget resulting from months of debate in a parliament with no absolute majority does not embrace the more radical cost-cutting measures originally proposed. It does raise funding for hospitals by EUR…

Saudi Arabia Baraya Extended Care is reshaping Saudi Arabia’s healthcare system, addressing critical gaps in long-term care and rehabilitation with bold innovation and a scalable vision. Backed by TVM Capital Healthcare Partners, it integrates advanced technologies and strategic partnerships to redefine specialized care while aligning with Vision 2030. As CEO Jad Halaby…

Hong Kong Prof. Lo Chung-mau, Hong Kong’s Secretary for Health, delves into some of the key strategic initiatives for advancing Hong Kong’s healthcare and biomedical innovation. Key topics include the integration of the Greater Bay Area (GBA) for enhanced clinical trials, addressing the increasing needs of Hong Kong healthcare system, and leveraging…

Saudi Arabia The Batterjee Group evolved from medical distribution in the 1920s to pioneering the first pharmacy chain in Saudi Arabia and establishing the largest private hospital network in the Middle East. They are expanding further into Asia and other regions, diversifying into areas like medical education, fitness, and IT healthcare solutions.…

France The biggest stories from French healthcare and pharma, including AstraZeneca’s acquisition of Amolyt Pharma; protests over Sanofi layoffs; Pierre Fabre’s purchase of Kinnate Biopharma’s  experimental pan-RAF inhibitor, and French biotech SeaBeLife’s EUR 1.5 million funding round.   Withdrawal of a flu vaccine due to a price dispute between Sanofi and…